USD 44.56
(-0.67%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | 65.7 Million | -27.76 Million |
Net Income | 53.63 Million | -27.08 Million | 41.48 Million | 21.16 Million | 65.7 Million | -27.76 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | -1.35 Million | -160.81 Thousand |
Other non-cash items | -53.63 Million | 27.08 Million | -41.48 Million | -21.16 Million | -65.7 Million | 27.76 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | -38.62 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | -2.59 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | -1.32 Million | -194.64 Thousand |
Accounts payables | - | - | - | - | -26 Thousand | 33.83 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 1.35 Million | 160.81 Thousand |
Cash at beginning of period | - | 2.12 Million | 235.69 Thousand | 86.58 Thousand | 261.00 | 170.00 |
Cash at end of period | - | 2.59 Million | 2.12 Million | 235.69 Thousand | 86.58 Thousand | 261.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 472.07 Thousand | 1.88 Million | 149.1 Thousand | 86.32 Thousand | 91.00 |
Free Cash Flow | - | - | - | - | 65.7 Million | -27.76 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 26.47 Million | 23.52 Million | 53.63 Million | 30.11 Million | -27.08 Million | 9.97 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -26.47 Million | -23.52 Million | -53.63 Million | -30.11 Million | 27.08 Million | -9.97 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | 2.59 Million | 2.12 Million | 1.86 Million |
Cash at end of period | - | - | - | 47.4 Thousand | 2.59 Million | 2.59 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | -2.54 Million | 472.07 Thousand | 728.06 Thousand |
Free Cash Flow | - | - | - | - | - | - |
1757
MCW
DLEXY
AJMPF
OXUR
300066